Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 40, 3547-3550, October 1, 1980]
© 1980 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Noble, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Noble, R. L.

Production of Nb Rat Carcinoma of the Dorsal Prostate and Response of Estrogen-dependent Transplants to Sex Hormones and Tamoxifen1

Robert L. Noble2

Department of Cancer Endocrinology, Cancer Control Agency of British Columbia, Vancouver, British Columbia, Canada V5Z 3J3

Carcinoma in the dorsal prostate of Nb rats was produced by prolonged treatment with androgen or androgen plus estrogen. The most effective combination was androgen followed by estrogen, resulting in an incidence of 50% in 10 rats. In such a case, the rats did not show evidence of androgenization. Transplants were usually not sensitive to hormones, but an estrogen-dependent tumor (Nb-2Pr-E) was successfully transplanted in estrogenized hosts. Cells of estrogen-dependent tumors did not grow in males but remained dormant and could be stimulated to grow after many months by estrogen treatment. The resulting tumors remained estrogen dependent, with one exception which was autonomous. Tumors regressed following estrogen removal but eventually showed a spontaneous regrowth which was then found to be autonomous. In the case of growing tumors, the reduction of estrogen to subthreshold doses for maximal growth allowed stationary or only slow growth of the tumors, but these remained estrogen dependent. Estrogen-dependent tumors responded to tamoxifen treatment by a cessation of tumor growth or regression despite continued estrogen treatment. Tumor regrowth eventually took place after prolonged tamoxifen treatment, but the tumors remained estrogen dependent when transplanted.

1 The research work was made possible by personal research funds.

2 Senior Research Investigator, Cancer Control Agency, Vancouver.

Received 10/ 2/79. Accepted 7/ 7/80.




This article has been cited by other articles:


Home page
Cancer Res.Home page
S. W. Hayward, Y. Wang, M. Cao, Y. K. Hom, B. Zhang, G. D. Grossfeld, D. Sudilovsky, and G. R. Cunha
Malignant Transformation in a Nontumorigenic Human Prostatic Epithelial Cell Line
Cancer Res., November 1, 2001; 61(22): 8135 - 8142.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K.-M. Lau, M. LaSpina, J. Long, and S.-M. Ho
Expression of Estrogen Receptor (ER)-{{alpha}} and ER-{beta} in Normal and Malignant Prostatic Epithelial Cells: Regulation by Methylation and Involvement in Growth Regulation
Cancer Res., June 1, 2000; 60(12): 3175 - 3182.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1980 by the American Association for Cancer Research.